U.S. RESEARCH ROUNDUP-Aspen Aerogels, Daseke, Karuna Therapeutics

Aemetis

26/12/2023 07:25

Dec 26 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Aspen Aerogels, Daseke and Karuna
Therapeutics, on Tuesday. 
    
      HIGHLIGHTS        
  
                 * Aspen Aerogels Inc  ASPN.N : Canaccord Genuity raises target price to $17 from
 $13 
 
                 * Daseke Inc  DSKE.O : Craig-Hallum cuts to hold rating
 
                 * Karuna Therapeutics  KRTX.O : Leerink Partners cuts to market perform from
 outperform  
 
                
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.   
 
                 * Aemetis Inc  AMTX.O : Ascendiant Capital Markets raises target price to $22.5
 from $22 
 
                 * Aspen Aerogels Inc  ASPN.N : Canaccord Genuity raises target price to $17 from
 $13 
 
                 * Atossa Therapeutics  ATOS.O : Ascendiant Capital Markets raises PT to $5.75 from
 $5.5 
 
                 * Carmax Inc  KMX.N : Stephens raises target price to $70 from $67 
 
                 * Daseke Inc  DSKE.O : Craig-Hallum cuts to hold rating 
 
                 * Daseke Inc  DSKE.O : Craig-Hallum raises target price to $8.3 
 
                 * Farmland Partners Inc  FPI.N : Raymond James raises target price to $15 from $14
 
                 * Karuna Therapeutics  KRTX.O : Leerink Partners cuts to market perform from
 outperform 
 
                 * Karuna Therapeutics  KRTX.O : Leerink Partners raises target price to $330 from
 $270 
 
                 * Karuna Therapeutics  KRTX.O : Oppenheimer raises target price to $330 from $280 
 
                 * Karuna Therapeutics  KRTX.O : Piper Sandler cuts to neutral from overweight 
 
                 * Karuna Therapeutics  KRTX.O : Piper Sandler raises target price to $330 from
 $268 
 
                 * Nrx Pharmaceuticals  NRXP.O : Ascendiant Capital Markets raises PT to $5.5 from
 $5.25 
 
                 * Sarepta Therapeutics Inc  SRPT.O : Evercore ISI raises target price to $108 from
 $94 
 
                 * Tandem Diabetes Care Inc  TNDM.O : Piper Sandler raises target price to $35 from
 $25 
 
                 * Winnebago Industries Inc  WGO.N : D.A. Davidson raises target price to $64 from
 $60 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))